glp 1 agonist medicine GLP-1 Drugs from the Gray Market Research shows GLP-1 receptor agonist

GLP-1 drugs may be prescribed for the following conditions as per American Diabetes Association/European Association for the Study of Diabetes (ADA/EASD) 2025 guidelines 11 : Primary glycaemic indication: GLP-1 RAs are recommended for adults with type 2 diabetes who have not reached their individualised A1C targets (typically when A1C is 1.5% above the agreed glycaemic goal) despite lifestyle measures and foundational therapy such as metformin

Recently, Ozempic-hungry Americans have crossed the border to raid Canadian pharmacies for the medication (securing over 15,000 doses by some estimates)

More users, more demand, and more competition

By improving insulin production, minimizing glucagon secretion, and impacting areas in the brain that control appetite, semaglutide can help reduce hunger and promote feelings of fullness

Tantai X, Liu Y, Yeo YH, Praktiknjo M, Mauro E, Hamaguchi Y, et al